Acurx Pharmaceuticals, Inc.
NASDAQ:ACXP
0.7199 (USD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||||||
Current Assets: | |||||||||||||||||
Cash & Cash Equivalents
| 5.763 | 6.361 | 8.921 | 7.474 | 7.052 | 9.146 | 7.179 | 9.112 | 10.607 | 9.092 | 11.083 | 12.959 | 14.459 | 17.096 | 2.628 | 3.175 | -2.483 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.967 |
Cash and Short Term Investments
| 5.763 | 6.361 | 8.921 | 7.474 | 7.052 | 9.146 | 7.179 | 9.112 | 10.607 | 9.092 | 11.083 | 12.959 | 14.459 | 17.096 | 2.628 | 3.175 | 2.483 |
Net Receivables
| 0.097 | 0.051 | 0 | 0.129 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 0.123 | 0.168 | 0.188 | 0.106 | 0.106 | 0.09 | 0.207 | 0.265 | 0.338 | 0.117 | 0.239 | 0.295 | 0.531 | 0.345 | 0.014 | 0.049 | 0 |
Total Current Assets
| 5.983 | 6.58 | 9.109 | 7.709 | 7.158 | 9.236 | 7.385 | 9.377 | 10.945 | 9.209 | 11.322 | 13.254 | 14.99 | 17.44 | 2.642 | 3.224 | 2.483 |
Non-Current Assets: | |||||||||||||||||
Property, Plant & Equipment, Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0 | 0 | 0 | 234.935 | 0 | 0 | 0 | 264.955 | 0 | 0.05 | 0 | 295.304 | 0 | 0 | 0.339 | 0 | -2.483 |
Total Non-Current Assets
| 0 | 0 | 0 | 234.935 | 0 | 0 | 0 | 264.955 | 0 | 0.05 | 0 | 295.304 | 0 | 0 | 0.339 | 0 | -2.483 |
Total Assets
| 5.983 | 6.58 | 9.109 | 7.709 | 7.158 | 9.236 | 7.385 | 9.377 | 10.945 | 9.259 | 11.322 | 13.254 | 14.99 | 17.44 | 2.982 | 3.224 | 0 |
Liabilities & Equity: | |||||||||||||||||
Current Liabilities: | |||||||||||||||||
Account Payables
| 0 | 0.01 | 0.009 | 0.004 | 0.012 | 0.013 | 0.018 | 0.03 | 0.006 | 0.006 | 0.006 | 0.063 | 0.012 | 0.097 | 0 | 0 | 0 |
Short Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.017 | 0.017 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
Other Current Liabilities
| 3,318.765 | 3.143 | 3.101 | 3.039 | 3.212 | 3.007 | 2.056 | 2.032 | 1.176 | 0.468 | 0.627 | 0.781 | 0.7 | 1.822 | 0.444 | 0.456 | 0 |
Total Current Liabilities
| 3,318.765 | 3.153 | 3.11 | 3.042 | 3.223 | 3.019 | 2.074 | 2.062 | 1.182 | 0.474 | 0.633 | 0.844 | 0.712 | 1.919 | 0.461 | 0.473 | 0 |
Non-Current Liabilities: | |||||||||||||||||
Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0.05 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.062 | 0 | 0.474 | 0 | 0 | 0 | 0 | 0.05 | 0.05 | 0 |
Total Liabilities
| 3.319 | 3.153 | 3.11 | 3.042 | 3.223 | 3.019 | 2.074 | 2.062 | 1.182 | 0.474 | 0.633 | 0.844 | 0.712 | 1.919 | 0.511 | 0.522 | 0 |
Equity: | |||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26.548 | 0 | 19.279 | 0 | 0 | 0 |
Common Stock
| 0.017 | 0.016 | 0.016 | 0.014 | 0.013 | 0.013 | 0.012 | 0.012 | 0.012 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 17.746 | 16.502 | 0 |
Retained Earnings
| -64.54 | -61.719 | -57.597 | -53.219 | -48.104 | -44.989 | -41.544 | -38.641 | -35.381 | -31.839 | -29.218 | -26.548 | -23.921 | -19.279 | -15.275 | -13.801 | 0 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -38.641 | -35.381 | -31.839 | -29.218 | -26.548 | -23.921 | -19.279 | -15.275 | -13.801 | 0.82 |
Other Total Stockholders Equity
| 67.187 | 65.13 | 63.58 | 57.871 | 52.026 | 51.193 | 46.844 | 84.586 | 45.132 | 40.614 | 39.897 | 38.948 | 38.188 | 34.791 | 0 | 13.801 | 0 |
Total Shareholders Equity
| 2.664 | 3.427 | 5.999 | 4.667 | 3.935 | 6.216 | 5.311 | 7.315 | 9.763 | 8.785 | 10.689 | 12.41 | 14.277 | 15.522 | 2.471 | 2.702 | 0.82 |
Total Equity
| 2.664 | 3.427 | 5.999 | 4.667 | 3.935 | 6.216 | 5.311 | 7.315 | 9.763 | 8.785 | 10.689 | 12.41 | 14.277 | 15.522 | 2.471 | 2.702 | 0.82 |
Total Liabilities & Shareholders Equity
| 5.983 | 6.58 | 9.109 | 7.709 | 7.158 | 9.236 | 7.385 | 9.377 | 10.945 | 9.259 | 11.322 | 13.254 | 14.99 | 17.44 | 2.982 | 3.224 | 0.82 |